Bio-Path Holdings Inc (BPTH)
2.77
-0.06
(-2.12%)
USD |
NASDAQ |
May 01, 16:00
2.78
+0.01
(+0.36%)
After-Hours: 20:00
Bio-Path Holdings Enterprise Value: 0.8283M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 0.8283M |
| April 30, 2024 | 0.869M |
| April 29, 2024 | 0.8826M |
| April 26, 2024 | 0.7672M |
| April 25, 2024 | 0.7366M |
| April 24, 2024 | 0.6382M |
| April 23, 2024 | 0.7706M |
| April 22, 2024 | 0.9301M |
| April 19, 2024 | 1.860M |
| April 18, 2024 | 1.799M |
| April 17, 2024 | 1.147M |
| April 16, 2024 | 1.018M |
| April 15, 2024 | 0.9437M |
| April 12, 2024 | 1.018M |
| April 11, 2024 | 1.086M |
| April 10, 2024 | 1.297M |
| April 09, 2024 | 1.541M |
| April 08, 2024 | 1.588M |
| April 05, 2024 | 1.806M |
| April 04, 2024 | 1.867M |
| April 03, 2024 | 1.869M |
| April 02, 2024 | 1.823M |
| April 01, 2024 | 2.070M |
| March 28, 2024 | 1.745M |
| March 27, 2024 | 1.690M |
| Date | Value |
|---|---|
| March 26, 2024 | 1.677M |
| March 25, 2024 | 1.514M |
| March 22, 2024 | 1.904M |
| March 21, 2024 | 1.853M |
| March 20, 2024 | 1.901M |
| March 19, 2024 | 2.043M |
| March 18, 2024 | 2.247M |
| March 15, 2024 | 2.070M |
| March 14, 2024 | 2.569M |
| March 13, 2024 | 2.620M |
| March 12, 2024 | 2.756M |
| March 11, 2024 | 2.512M |
| March 08, 2024 | 2.905M |
| March 07, 2024 | 3.177M |
| March 06, 2024 | 3.320M |
| March 05, 2024 | 2.846M |
| March 04, 2024 | 2.797M |
| March 01, 2024 | 2.686M |
| February 29, 2024 | 2.704M |
| February 28, 2024 | 2.673M |
| February 27, 2024 | 2.105M |
| February 26, 2024 | 2.531M |
| February 23, 2024 | 2.562M |
| February 22, 2024 | 3.419M |
| February 21, 2024 | 4.418M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.092M
Minimum
Mar 16 2020
40.02M
Maximum
Feb 18 2021
7.463M
Average
4.899M
Median
Jan 17 2023
Enterprise Value Benchmarks
| INVO Bioscience Inc | 11.27M |
| EyePoint Pharmaceuticals Inc | 567.90M |
| Hepion Pharmaceuticals Inc | -5.648M |
| Aileron Therapeutics Inc | 53.46M |
| Protara Therapeutics Inc | -32.31M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.372M |
| Total Expenses (Quarterly) | 3.033M |
| EPS Diluted (Quarterly) | -4.23 |
| Earnings Yield | -1.24K% |
| Normalized Earnings Yield | -14449.76 |